Central Proteina Price To Sales vs. Current Valuation

CPRO Stock  IDR 50.00  0.00  0.00%   
Based on the key profitability measurements obtained from Central Proteina's financial statements, Central Proteina Prima may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Central Proteina's ability to earn profits and add value for shareholders.
For Central Proteina profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Central Proteina to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Central Proteina Prima utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Central Proteina's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Central Proteina Prima over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Central Proteina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Central Proteina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Central Proteina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Central Proteina Prima Current Valuation vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Central Proteina's current stock value. Our valuation model uses many indicators to compare Central Proteina value to that of its competitors to determine the firm's financial worth.
Central Proteina Prima is number one stock in price to sales category among its peers. It also is the top company in current valuation category among its peers reporting about  Huge  of Current Valuation per Price To Sales. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Central Proteina's earnings, one of the primary drivers of an investment's value.

Central Current Valuation vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Central Proteina

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.39 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Central Proteina

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
5.48 T
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Central Current Valuation vs Competition

Central Proteina Prima is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Consumer Staples industry is currently estimated at about 328.08 Trillion. Central Proteina claims roughly 5.48 Trillion in current valuation contributing just under 2% to stocks in Consumer Staples industry.

Central Proteina Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Central Proteina, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Central Proteina will eventually generate negative long term returns. The profitability progress is the general direction of Central Proteina's change in net profit over the period of time. It can combine multiple indicators of Central Proteina, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people.

Central Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Central Proteina. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Central Proteina position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Central Proteina's important profitability drivers and their relationship over time.

Use Central Proteina in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Central Proteina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Central Proteina will appreciate offsetting losses from the drop in the long position's value.

Central Proteina Pair Trading

Central Proteina Prima Pair Trading Analysis

The ability to find closely correlated positions to Central Proteina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Central Proteina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Central Proteina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Central Proteina Prima to buy it.
The correlation of Central Proteina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Central Proteina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Central Proteina Prima moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Central Proteina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Central Proteina position

In addition to having Central Proteina in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Conservative Funds Thematic Idea Now

Conservative Funds
Conservative Funds Theme
Funds or Etfs that invest using buy-and-hold investment strategy in companies with consistent growth over many years of operation. The Conservative Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Conservative Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Central Stock

To fully project Central Proteina's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Central Proteina Prima at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Central Proteina's income statement, its balance sheet, and the statement of cash flows.
Potential Central Proteina investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Central Proteina investors may work on each financial statement separately, they are all related. The changes in Central Proteina's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Central Proteina's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.